Quantcast
Close Window
   
Welcome to 2018 :o)
As the lawsuits against Johnson & Johnson continue to pile up, looks like another year of the same Johnson & Johnson shit, unfettered by laws, regulations, ethics or even basic human compassion.
 
Just another year of bleeding people dry and then spitting out the corpse, slaughtering people faster than an ISIS wet dream.
 
Looks more and more like the biggest risk to Americans is Johnson & Johnson ;o)
HomeAbout

Content List
100+ articles of harm and corruption by Johnson & Johnson and subsidiary products.
Click for content list...

 
This is INDEPENDENT, AD-FREE work that you are certainly NOT going to see in conventional media.
 
List of content exposing harm and corruption compiled since March of 2012
 
So far, as of January 19, 2018, there has been only ONE gift of support. Could use a little more help, please.
 
The people most at risk for harm by a known defective Johnson & Johnson product are those who can afford their outrageously priced products and those with health insurance; basically those who make over $100,000 per year.
 
If you'd like to help keep me writing, tweeting the information to Trump, US Senate, US Attorneys General, State Governors, US government health agencies such as FDA/CDC, etc, useless (fake) media, JNJ shareholders, it would be much appreciated if you would send a gift to help keep this effort going....
 
Next planned articles...
Done... Pharma Company Facing Over 108,000 Lawsuits Awarded $300 Million in Defense Department Contracts
 
On the list to do after I receive the next gift of support...
Kudos to Trump for Cutting Millions of Poor From Medicaid
Johnson & Johnson Innovative Population Control Strategy
Founder of Apotex and Wife Found Hung in Home Likely Visited JohnsonAndToxin Site Researching ....
Johnson & Johnson CEO Gorsky Wants to "CREATE A CRISIS"; gee, looks like he already did ;o)
 
Thank you,   
Emily
 
$.00         
 
JOHNSON & JOHNSON PARTIAL USA LAWSUIT LIST...
 
Baby powder ovarian cancer lawsuits
Metal-on-metal hip lawsuits
Xarelto DEATH and bleed-out lawsuits
Hernia and transvaginal mesh lawsuits
Invokana ketoacidosis, etc. lawsuits
Deadly, disabling Risperdal lawsuits
Deadly, disabling Levaquin lawsuits
* Velcade overcharging lawsuits
* Procrit heart attack lawsuits
* Stelera cancer lawsuits
* Morcellators uterine cancer lawsuits
* Tylenol death and liver failure lawsuits
* Defective diabetes device lawsuits
* Defective heart stent lawsuits
* Death and disability spine disc lawsuits
* Deadly bone cement lawsuits "Pigs injected with the cement died within minutes"
* Deadly, disabling opioid lawsuits
* Defective knee lawsuits
* Defective elbow lawsuits
* Deadly defective surgical tool lawsuits
* Topamax birth defect and suicide lawsuits
 
* NEW: January 2, 2018, CLASS ONE RECALL of heart device
 
This list is NOT all-inclusive and covers ONLY lawsuits in the United States.
 
* NOT mentioned on 2017 3rd 1/4 10Q

Glad to see you :o)
Notable visitors to the web site include:
 
US GOVERNMENT:
United States Air Force
US Senate
US Department of Defense
US Department of Justice
US Homeland Security
US Centers for Disease Control
 
GLOBAL FINANCIAL INSTITUTIONS:
Vanguard
Barclays
The Bank of New York Mellon Corp
Lloyds Banking Group PLC
Royal Bank of Canada
Bank of America
Harris Trust & Savings Bank
Deutsche Bank
Macquarie Bank
PNC Bank
Crédit Agricole Bank
Royal Bank of Scotland
Raymond James Financial
BlackRock Financial Management
...and many, many more from all over the world ;o)
 
Feel free to browse list of notable visitors to the web site.
 

Johnson & Johnson Consumer Sales Continue to Drop, 2011 to 2013
Johnson & Johnson consumer goods sales continue to slide in 2013 due to boycotts, recalls and more carcinogens in baby care products.

Keywords: jnj, johnson and johnson, johnson & johnson, J&J, boycott, recall, baby, products
Date Created/Edited: 2013, May 12
 

Most Recent Content....
Pharma Company Facing Over 108,000 Lawsuits Awarded $300 Million in Defense Department Contracts
Nothing like the best for United States Veterens, eh?
 
Johnson & Johnson Adds Another Two Thousand Lawsuits in Third Quarter 2017
Lawsuits against Johnson & Johnson continue to spiral out of control - breaking over 108,000 in third quarter 2017, with numerous unmentioned products also racking up an untold number of lawsuits not mentioned in 2017 10-Q.
 
History of Johnson & Johnson Janssen Fentanyl
Hmm, looks like Johnson & Johnson is profiting from BOTH sides of opioid addiction crisis ;o)
 
15 Steps to Solve Healthcare Crisis
How about this for a rough outline of a strategy to dramatically reduce healthcare costs?
 
ACA the Affordable CORRUPTION Act
The only purpose of the ACA/ObamaCare was to force everyone to pay legal fees and victim settlements and care from harm by Johnson & Johnson.
 
Johnson & Johnson Begs US FDA to Expand Xarelto Slaughter
After killing around 2,000 people in the United States in 2016 alone, Johnson & Johnson wants to spread the deaths even more!
 
Johnson & Johnson Facing Over $100 BILLION in Lawsuit Debt
With a flood of lawsuits pouring in from around the world, Johnson & Johnson is facing at least $100 BILLION lawsuit debt.
 
The Johnson & Johnson Drugged Kids Pension Plan
Teacher and state retirement funds invest in Johnson & Johnson, the DRUGGED KIDS PENSION PLAN
 
Second Quarter 2017 Lawsuits Against Johnson & Johnson
Lawsuits against Johnson & Johnson in United States holding at 106,600! DOES NOT INCLUDE ALL PRODUCTS FACING LAWSUITS OR LAWUITS FILED OUTSIDE THE UNITED STATES!
 
Special Sections....
Mesh Files
Baby Powder (talc) Files
Risperdal Files
Levaquin Files
Xarelto Files
Hips Files
Letters to Shareholders
SEC Lawsuits Files

 
Recent Content....
Why President Trump Should Shut Down US FDA (2017, March 28)
Healthcare organizations around the world depend on US FDA decisions, however, profit, rather than safety, seems to be the primary motivation.
healthcare, health, obamacare, donald, trump, fda, fraud, kickback
 
The Difference Between Guinea Pig and Cash Cow (2016, September 27)
People keep saying pharma is using us as 'guinea pigs'. Uh, not quite. Take a minute to learn the difference between a 'guinea pig' and a 'cash cow'.
guinea pig, immunization, vaccination, profit, harm, autism, disability, asthma
 
Johnson & Johnson Victims at Risk of RE-Victimization (2016, August 22)
If you are currently a victim of a known harmful Johnson & Johnson subsidiary product and have high medical needs due to your injuries, you are at increased risk of becoming a victim of another known harmful Johnson & Johnson subsidiary product.
jnj, johnson and johnson, johnson & johnson, victim, mesh, hip, levaquin, risperdal
 
Johnson & Johnson Animas Defective Diabetes Devices (2016, August 4)
Gosh and golly gee willikers, yet another Johnson & Johnson subsidiary, Animas, totally sucks, jah?
Johnson and Johnson, Johnson & Johnson, animas, vibe, diabetes, insulin, device, pump
 
Johnson & Johnson Ethicrap, I Mean EthiCON, More JNJ JUNK (2016, July 25)
As I've mentioned, Johnson & Johnson has so many bad products I have to put a bunch in each article now to try to keep up. Now for EthiCON crap.
Johnson and Johnson, Johnson & Johnson, ethicon, harmonic ace, morcellator, physiomesh, secure strap, stapler
 
Numerous groups have called for boycotts of Johnson & Johnson products for a variety of reasons. In addition, as more mothers in the United States are educated regarding known carcinogens in the U.S. formulation of baby soap, shampoo, powder, lotions, creams and other baby products as well as the same carcinogens in adult care products, it is obvious that the sales of J&J toxic consumer products are suffering as consumers choose less toxic products.
 
2011 : 2011 consumer sales : U.S. decrease 6.7% / Int increase 7.3 / WW increase 2.0%
http://www.investor.jnj.com/2011annualreport/pdf/JNJ-2011_ManagementsDiscussion_AnalysisSales.pdf page 2 of 11
 
2012 : 1st quarter consumer sales : U.S. decrease 2.2% / Int decrease 2.5% / WW decrease 2.4%
Worldwide Consumer sales of $3.6 billion for the first quarter represented a decrease of 2.4% versus the prior year consisting of an operational decline of 0.6% and a negative impact from currency of 1.8%. Domestic sales decreased 2.2%. International sales decreased 2.5%, which reflected an operational increase of 0.4% and a negative currency impact of 2.9%.
http://www.jnj.com/connect/news/all/johnson-and-johnson-reports-2012-first-quarter-results
 
2012 : 2nd quarter consumer sales : U.S. decrease 1.9% / Int decrease 6.0% / WW decrease 4.6%
Worldwide Consumer sales of $3.6 billion for the second quarter represented a decrease of 4.6% versus the prior year consisting of an operational increase of 0.6% and a negative impact from currency of 5.2%. Domestic sales decreased 1.9%. International sales decreased 6.0%, which reflected an operational increase of 2.0% and a negative currency impact of 8.0%.
http://www.jnj.com/connect/news/all/johnson-and-johnson-reports-2012-second-quarter-results
 

2012 : 3rd quarter consumer sales : U.S. decrease 4.3% / Int decrease 6.1% / WW decrease 4.3%
Worldwide Consumer sales of $3.6 billion for the third quarter represented a decrease of 4.3% versus the prior year consisting of an operational increase of 1.0% and a negative impact from currency of 5.3%. Domestic sales decreased 0.4%. International sales decreased 6.1%, which reflected an operational increase of 1.8% and a negative currency impact of 7.9%.
http://www.jnj.com/connect/news/all/johnson-and-johnson-reports-2012-third-quarter-results
 
2012 : full year consumer sales : U.S. decrease 2% / Int decrease 3.4% / WW decrease 2.9%
Worldwide Consumer sales of $14.4 billion for the full-year 2012 represented a decrease of 2.9% versus the prior year, consisting of an operational increase of 0.5% and a negative impact from currency of 3.4%. Domestic sales decreased 2.0%; international sales decreased 3.4%, which reflected an operational increase of 1.9% and a negative currency impact of 5.3%.
http://www.jnj.com/connect/news/all/johnson-and-johnson-reports-2012-fourth-quarter-and-full-year-results
 
With yet another recall of Children's Tylenol and yet another undisclosed carcinogen found in yet another baby care product, I don't see Johnson & Johnson consumer sales rebounding any time soon. I don't know, maybe people don't want to risk using products on their children that might harm their precious babies. As people like me continue sharing the risks as fast as we can with other moms so they don't use toxic products, I think sales will likely continue to drop.
 
Something to consider: As fewer people use toxic products from Johnson & Johnson, the rate of long-term illnesses, such as asthma, allergies, chronic sinus infections, COPD, cancer, low fertility, and such, caused by these products (and the drugs prescribed to deal with side effects of the drugs prescribed) will begin to decline - cutting into Johnson & Johnson medical devices and pharmaceuticals sales ;o)
 
Resources:
1. Elizabeth Lopatto (2013, May 3). J&J Recalls Some Children’s Tylenol in South Korea Bloomberg. Retrieved from http://www.bloomberg.com/news/2013-05-03/j-j-recalls-some-children-s-tylenol-in-south-korea.html
 
2. Ganesh N (2013, April 25). FDA suspends J&J Licence New indian Express. Retrieved from http://www.newindianexpress.com/nation/FDA-suspends-JJ-Licence/2013/04/25/article1560077.ece
 
 
 
 
 
 
 
 
 
All contents Copyright © 2012-2017 Emily Patterson / Johnson and Toxin. All rights reserved.
 
Web Site and Admin Info:
Home
About
Contact
Disclaimers
Privacy Policy
Site Statistics
Site Resources
Financial Disclosure

 
Recently Posted:
2015 Johnson & Johnson US Lawsuit Update: Jump from 48,500 to 56.500
 
Johnson & Johnson Plans to Expand Healthcare Cost Crisis and Product Liability in Asia
 
Who REALLY Pays for Drug Development? US TAXPAYERS - $21 BILLION for fiscal year 2014
 
Johnson & Johnson Janssen Xarelto Marketed In Violation of FDA Regulations
 
Johnson & Johnson Destroys Thousands of Files Related to Vaginal Mesh
 
Johnson & Johnson: The Global Lawsuit Company


 
 
Most Popular:
The Ever-Growing Number of Lawsuits Against Johnson & Johnson
 
Johnson & Johnson Credo Analysis
 
Johnson & Johnson $4 Billion for DePuy Hip Harm in U.S., With Lawsuits in at Least 4 More Countries